<bill session="113" type="s" number="959" updated="2023-01-11T13:24:36Z">
  <state datetime="2013-05-22">REPORTED</state>
  <status>
    <unknown datetime="2013-05-22"/>
  </status>
  <introduced datetime="2013-05-15"/>
  <titles>
    <title type="display">Pharmaceutical Quality, Security, and Accountability Act</title>
    <title type="official" as="introduced">A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to compounding drugs.</title>
    <title type="short" as="introduced">Pharmaceutical Compounding Quality and Accountability Act</title>
    <title type="short" as="reported to senate">Pharmaceutical Quality, Security, and Accountability Act</title>
    <title type="short" as="reported to senate" partial="1">Drug Supply Chain Security Act</title>
    <title type="short" as="reported to senate" partial="1">Pharmaceutical Compounding Quality and Accountability Act</title>
  </titles>
  <sponsor bioguide_id="H000206"/>
  <cosponsors>
    <cosponsor bioguide_id="A000360" joined="2013-05-15"/>
    <cosponsor bioguide_id="F000457" joined="2013-05-15"/>
    <cosponsor bioguide_id="M000702" joined="2013-05-15"/>
    <cosponsor bioguide_id="R000307" joined="2013-05-15"/>
    <cosponsor bioguide_id="W000817" joined="2013-05-16"/>
  </cosponsors>
  <actions>
    <action datetime="2013-05-15">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2013-05-15" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
    <action datetime="2013-05-22" state="REPORTED">
      <text>Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.</text>
    </action>
    <action datetime="2013-06-19">
      <text>Committee on Health, Education, Labor, and Pensions. Reported by Senator Harkin with an amendment in the nature of a substitute and an amendment to the title. Without written report.</text>
    </action>
    <calendar datetime="2013-06-19" calendar="Senate Legislative" under="General Orders" number="89">
      <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 89.</text>
    </calendar>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Reporting, Markup, Referral"/>
  </committees>
  <relatedbills>
    <bill session="113" type="h" number="3204" relation="unknown"/>
    <bill session="113" type="s" number="957" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Business records"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Federal preemption"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Licensing and registrations"/>
    <term name="Prescription drugs"/>
    <term name="Retail and wholesale trades"/>
    <term name="Small business"/>
    <term name="State and local government operations"/>
    <term name="User charges and fees"/>
    <term name="Veterinary medicine and animal diseases"/>
  </subjects>
  <amendments>
    <amendment number="s1829"/>
    <amendment number="s1828"/>
    <amendment number="s1827"/>
    <amendment number="s1826"/>
  </amendments>
  <summary date="2013-10-16T22:37:58Z" status="Introduced in Senate">Pharmaceutical Compounding Quality and Accountability Act - Sets forth provisions to revise the regulations regarding human compounding. Establishes requirements for animal drug compounding and biological product compounding. Requires the compounding manufacturers to: (1) register with the Secretary of Health and Human Services (HHS) annually, (2) report to the Secretary on the drugs it compounds, and (3) report serious adverse events associated with the use of compounded drugs. Requires the Secretary to assess establishment and reinspection fees.</summary>
</bill>
